Tools

LEADER 02738cam a2200493 i 4500

001 ocm04696724;

003 OCoLC;

005 20150728095119.0;

008 790524s1978 dcu b f000 0 eng ;

010 a| 79600925;

035 a| (Sirsi) o04696724;

035 a| (OCoLC)4696724;

043 a| n-us---;

049 a| ERE#;

050 04 a| KF27b| .G664 1978a;

060 4 a| QV 177 U58q 1978;

082 0 a| 344/.73/042;

086 0 a| Y 4.G 74/7:Sci 2/2;

245 10 a| Quality of scientific evidence in FDA regulatory decisions :b| the adoption of an antismoking warning in oral contraceptive pill labeling : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fifth Congress, second session, October 4, 1978.;

260 a| Washington :b| U.S. Govt. Print. Off,c| 1978.;

300 a| iv, 293 pages ;c| 24 cm;

336 a| textb| txt2| rdacontent;

337 a| unmediatedb| n2| rdamedia;

338 a| volumeb| nc2| rdacarrier;

504 a| Includes bibliographical references.;

650 0 a| Oral contraceptivesx| Labelingz| United States.=| ^A44919;

610 10 a| United States.b| Food and Drug Administration.=| ^A1253;

650 2 a| Contraceptives, Oralx| adverse effects.=| ^A1266764;

650 2 a| Myocardial Infarctionx| etiology.=| ^A1266803;

650 2 a| Product Labeling.=| ^A1018009;

650 2 a| Smokingx| complications.=| ^A917992;

650 7 a| Oral contraceptivesx| Labeling.2| fast0| (OCoLC)fst01047035;

651 7 a| United States.2| fast0| (OCoLC)fst01204155?| UNAUTHORIZED;

776 08 i| Online version:a| United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee.t| Quality of scientific evidence in FDA regulatory decisions.d| Washington : U.S. Govt. Print. Off., 1978w| (OCoLC)608121431;

938 a| AMAZONb| AMZNn| B00300GHPY;

994 a| C0b| ERE;

596 a| 1;

998 a| 3766887;

999 a| Y 4.G 74/7:SCI 2/2w| SUDOCc| 1i| 30372016703305l| JDOSm| JOYNERr| Ys| Yt| JDOSBKu| 6/10/2015x| BOOKz| JFEDDOCSo| .STAFF. jmpl;

Quality of scientific evidence in FDA regulatory decisions : the adoption of an antismoking warning in oral contraceptive pill labeling : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fifth Congress, second session, October 4, 1978.

Author/creator	United States
Format	Book
Publication Info	Washington : U.S. Govt. Print. Off, 1978.
Description	iv, 293 pages ; 24 cm
Subjects	United States. Food and Drug Administration. Oral contraceptives--Labeling. --United States. Contraceptives, Oral--adverse effects. Myocardial Infarction--etiology. Product Labeling. Smoking--complications.

Bibliography note	Includes bibliographical references.
Issued in other form	Online version: United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee. Quality of scientific evidence in FDA regulatory decisions. Washington : U.S. Govt. Print. Off., 1978
Issued in other form	Online version: United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee. Quality of scientific evidence in FDA regulatory decisions. Washington : U.S. Govt. Print. Off., 1978
LCCN	79600925
Govt. docs number	Y 4.G 74/7:Sci 2/2

Availability

Library	Location	Call Number	Status	Item Actions
Joyner	Fed Docs Stacks	Y 4.G 74/7:SCI 2/2	✔ Available	Place Hold

Quality of scientific evidence in FDA regulatory decisions : the adoption of an antismoking warning in oral contraceptive pill labeling : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fifth Congress, second session, October 4, 1978.

Click here for more information about this title

Availability